E
Standard BioTools Inc.
LAB
$1.18
$0.098.26%
E
Sell
3/31/2025Downgrade
Standard BioTools Inc. (LAB) was downgraded to E+ from D- on 3/31/2025 due to a decline in the volatility index and total return index.
Standard BioTools Inc. (LAB) was downgraded to E+ from D- on 3/31/2025 due to a decline in the volatility index and total return index.
D
Sell
3/14/2025Upgraded
Standard BioTools Inc. (LAB) was upgraded to D- from E+ on 3/14/2025 due to an increase in the volatility index and solvency index. Debt to equity declined from 0.13 to 0.01, and the quick ratio increased from 3.33 to 4.95.
Standard BioTools Inc. (LAB) was upgraded to D- from E+ on 3/14/2025 due to an increase in the volatility index and solvency index. Debt to equity declined from 0.13 to 0.01, and the quick ratio increased from 3.33 to 4.95.
E
Sell
2/26/2025Downgrade
Standard BioTools Inc. (LAB) was downgraded to E+ from D- on 2/26/2025 due to a decline in the volatility index and valuation index.
Standard BioTools Inc. (LAB) was downgraded to E+ from D- on 2/26/2025 due to a decline in the volatility index and valuation index.
D
Sell
3/14/2023Downgrade
Standard BioTools Inc. (LAB) was downgraded to D- from D on 03/14/2023.
Standard BioTools Inc. (LAB) was downgraded to D- from D on 03/14/2023.
D
Sell
1/31/2023Upgraded
Standard BioTools Inc. (LAB) was upgraded to D from D- on 1/31/2023 due to a noticeable increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.82 to -$0.373, total revenue increased 36.58% from $18.78M to $25.65M, and EBIT increased 30.55% from -$38.56M to -$26.78M.
Standard BioTools Inc. (LAB) was upgraded to D from D- on 1/31/2023 due to a noticeable increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.82 to -$0.373, total revenue increased 36.58% from $18.78M to $25.65M, and EBIT increased 30.55% from -$38.56M to -$26.78M.
D
Sell
9/19/2022Upgraded
Standard BioTools Inc. (LAB) was upgraded to D- from E+ on 9/19/2022 due to an increase in the volatility index and total return index.
Standard BioTools Inc. (LAB) was upgraded to D- from E+ on 9/19/2022 due to an increase in the volatility index and total return index.
E
Sell
9/1/2022Downgrade
Standard BioTools Inc. (LAB) was downgraded to E+ from D- on 9/1/2022 due to a decline in the volatility index.
Standard BioTools Inc. (LAB) was downgraded to E+ from D- on 9/1/2022 due to a decline in the volatility index.
D
Sell
8/12/2022Upgraded
Standard BioTools Inc. (LAB) was upgraded to D- from E+ on 8/12/2022 due to a noticeable increase in the solvency index and valuation index. The quick ratio increased from 0.96 to 5.19, and debt to equity declined from 4.67 to -1.81.
Standard BioTools Inc. (LAB) was upgraded to D- from E+ on 8/12/2022 due to a noticeable increase in the solvency index and valuation index. The quick ratio increased from 0.96 to 5.19, and debt to equity declined from 4.67 to -1.81.
E
Sell
6/21/2022Downgrade
Standard BioTools Inc. (LAB) was downgraded to E+ from D- on 6/21/2022 due to a decline in the total return index.
Standard BioTools Inc. (LAB) was downgraded to E+ from D- on 6/21/2022 due to a decline in the total return index.
D
Sell
5/31/2022Upgraded
Standard BioTools Inc. (LAB) was upgraded to D- from E+ on 5/31/2022 due to an increase in the valuation index.
Standard BioTools Inc. (LAB) was upgraded to D- from E+ on 5/31/2022 due to an increase in the valuation index.
E
Sell
5/13/2022Downgrade
Standard BioTools Inc. (LAB) was downgraded to E+ from D- on 5/13/2022 due to a decline in the total return index.
Standard BioTools Inc. (LAB) was downgraded to E+ from D- on 5/13/2022 due to a decline in the total return index.
D
Sell
5/10/2022Downgrade
Standard BioTools Inc. (LAB) was downgraded to D- from D on 5/10/2022 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from -$0.123 to -$0.9904, debt to equity increased from 0.78 to 4.67, and EBIT declined 144.28% from -$11.26M to -$27.5M.
Standard BioTools Inc. (LAB) was downgraded to D- from D on 5/10/2022 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from -$0.123 to -$0.9904, debt to equity increased from 0.78 to 4.67, and EBIT declined 144.28% from -$11.26M to -$27.5M.
D
Sell
5/4/2022Upgraded
Standard BioTools Inc. (LAB) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index and total return index.
Standard BioTools Inc. (LAB) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index and total return index.
E
Sell
5/1/2022Downgrade
Standard BioTools Inc. (LAB) was downgraded to E+ from D- on 5/1/2022 due to a decline in the volatility index.
Standard BioTools Inc. (LAB) was downgraded to E+ from D- on 5/1/2022 due to a decline in the volatility index.
D
Sell
4/20/2022Downgrade
Standard BioTools Inc. (LAB) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.67 to 0.78.
Standard BioTools Inc. (LAB) was downgraded to D- from D on 4/20/2022 due to a decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.67 to 0.78.
D
Sell
11/11/2021Upgraded
Fluidigm Corporation (FLDM) was upgraded to D from D- on 11/11/2021 due to an increase in the volatility index.
Fluidigm Corporation (FLDM) was upgraded to D from D- on 11/11/2021 due to an increase in the volatility index.
D
Sell
11/8/2021Downgrade
Fluidigm Corporation (FLDM) was downgraded to D- from D on 11/8/2021 due to a noticeable decline in the solvency index, total return index and valuation index. The quick ratio declined from 1.32 to 0.93, and debt to equity increased from 0.46 to 0.52.
Fluidigm Corporation (FLDM) was downgraded to D- from D on 11/8/2021 due to a noticeable decline in the solvency index, total return index and valuation index. The quick ratio declined from 1.32 to 0.93, and debt to equity increased from 0.46 to 0.52.
D
Sell
2/26/2021Downgrade
Fluidigm Corporation (FLDM) was downgraded to D from D+ on 2/26/2021 due to a significant decline in the growth index, total return index and solvency index. EBIT declined 209.37% from -$5.46M to -$16.9M, earnings per share declined from -$0.0828 to -$0.2427, and the quick ratio declined from 2.28 to 1.73.
Fluidigm Corporation (FLDM) was downgraded to D from D+ on 2/26/2021 due to a significant decline in the growth index, total return index and solvency index. EBIT declined 209.37% from -$5.46M to -$16.9M, earnings per share declined from -$0.0828 to -$0.2427, and the quick ratio declined from 2.28 to 1.73.
D
Sell
2/22/2021Upgraded
Fluidigm Corporation (FLDM) was upgraded to D+ from D on 2/22/2021 due to an increase in the volatility index and valuation index.
Fluidigm Corporation (FLDM) was upgraded to D+ from D on 2/22/2021 due to an increase in the volatility index and valuation index.
D
Sell
2/1/2021Downgrade
Fluidigm Corporation (FLDM) was downgraded to D from D+ on 2/1/2021 due to a decline in the valuation index.
Fluidigm Corporation (FLDM) was downgraded to D from D+ on 2/1/2021 due to a decline in the valuation index.
D
Sell
1/15/2021Upgraded
Fluidigm Corporation (FLDM) was upgraded to D+ from D on 1/15/2021 due to a noticeable increase in the growth index and volatility index. EBIT increased 60.19% from -$13.73M to -$5.46M, earnings per share increased from -$0.1835 to -$0.0828, and total revenue increased 52.97% from $26.06M to $39.86M.
Fluidigm Corporation (FLDM) was upgraded to D+ from D on 1/15/2021 due to a noticeable increase in the growth index and volatility index. EBIT increased 60.19% from -$13.73M to -$5.46M, earnings per share increased from -$0.1835 to -$0.0828, and total revenue increased 52.97% from $26.06M to $39.86M.
D
Sell
9/17/2019Downgrade
Fluidigm Corporation (FLDM) was downgraded to D from D+ on 9/17/2019 due to a decline in the volatility index, growth index and efficiency index. Total revenue declined 6.36% from $30.11M to $28.2M, total capital declined 4.27% from $240.93M to $230.64M, and EBIT declined 3.03% from -$14.21M to -$14.64M.
Fluidigm Corporation (FLDM) was downgraded to D from D+ on 9/17/2019 due to a decline in the volatility index, growth index and efficiency index. Total revenue declined 6.36% from $30.11M to $28.2M, total capital declined 4.27% from $240.93M to $230.64M, and EBIT declined 3.03% from -$14.21M to -$14.64M.
D
Sell
10/8/2018Upgraded
Fluidigm Corporation (FLDM) was upgraded to D+ from D on 10/8/2018 due to a substantial increase in the total return index, growth index and volatility index. Operating cash flow increased 73.28% from -$16.18M to -$4.32M, and total revenue increased 4.67% from $25.25M to $26.43M.
Fluidigm Corporation (FLDM) was upgraded to D+ from D on 10/8/2018 due to a substantial increase in the total return index, growth index and volatility index. Operating cash flow increased 73.28% from -$16.18M to -$4.32M, and total revenue increased 4.67% from $25.25M to $26.43M.
D
Sell
11/9/2017Upgraded
Fluidigm Corporation (FLDM) was upgraded to D from D- on 11/9/2017 due to an increase in the growth index and volatility index. Earnings per share increased from -$0.5771 to -$0.462, EBIT increased 5.37% from -$16.49M to -$15.6M, and operating cash flow increased 3.73% from -$8.29M to -$7.98M.
Fluidigm Corporation (FLDM) was upgraded to D from D- on 11/9/2017 due to an increase in the growth index and volatility index. Earnings per share increased from -$0.5771 to -$0.462, EBIT increased 5.37% from -$16.49M to -$15.6M, and operating cash flow increased 3.73% from -$8.29M to -$7.98M.
D
Sell
3/6/2017Downgrade
Fluidigm Corporation (FLDM) was downgraded to D- from D on 3/6/2017 due to a decline in the solvency index, valuation index and efficiency index. Debt to equity increased from 2.87 to 3.66, the quick ratio declined from 3.01 to 2.51, and total capital declined 5.58% from $262.85M to $248.18M.
Fluidigm Corporation (FLDM) was downgraded to D- from D on 3/6/2017 due to a decline in the solvency index, valuation index and efficiency index. Debt to equity increased from 2.87 to 3.66, the quick ratio declined from 3.01 to 2.51, and total capital declined 5.58% from $262.85M to $248.18M.
D
Sell
3/1/2017Upgraded
Fluidigm Corporation (FLDM) was upgraded to D from D- on 3/1/2017 due to an increase in the total return index.
Fluidigm Corporation (FLDM) was upgraded to D from D- on 3/1/2017 due to an increase in the total return index.
D
Sell
11/11/2016Downgrade
Fluidigm Corporation (FLDM) was downgraded to D- from D on 11/11/2016 due to a major decline in the volatility index, total return index and solvency index. Debt to equity increased from 2.31 to 2.87, and the quick ratio declined from 3.26 to 3.01.
Fluidigm Corporation (FLDM) was downgraded to D- from D on 11/11/2016 due to a major decline in the volatility index, total return index and solvency index. Debt to equity increased from 2.31 to 2.87, and the quick ratio declined from 3.26 to 3.01.
D
Sell
3/3/2016Downgrade
Fluidigm Corporation (FLDM) was downgraded to D from D+ on 3/3/2016 due to a noticeable decline in the growth index, efficiency index and solvency index. Operating cash flow declined 65.61% from -$12.7M to -$4.37M, the quick ratio declined from 4.49 to 4, and debt to equity increased from 1.58 to 1.7.
Fluidigm Corporation (FLDM) was downgraded to D from D+ on 3/3/2016 due to a noticeable decline in the growth index, efficiency index and solvency index. Operating cash flow declined 65.61% from -$12.7M to -$4.37M, the quick ratio declined from 4.49 to 4, and debt to equity increased from 1.58 to 1.7.
D
Sell
1/15/2016Downgrade
Fluidigm Corporation (FLDM) was downgraded to D+ from C- on 1/15/2016 due to a noticeable decline in the total return index.
Fluidigm Corporation (FLDM) was downgraded to D+ from C- on 1/15/2016 due to a noticeable decline in the total return index.
C
Hold
12/31/2015Upgraded
Fluidigm Corporation (FLDM) was upgraded to C- from D+ on 12/31/2015 due to a noticeable increase in the growth index and valuation index. Operating cash flow increased 62.22% from -$7.83M to -$12.7M, and total revenue increased 0.09% from $28.62M to $28.64M.
Fluidigm Corporation (FLDM) was upgraded to C- from D+ on 12/31/2015 due to a noticeable increase in the growth index and valuation index. Operating cash flow increased 62.22% from -$7.83M to -$12.7M, and total revenue increased 0.09% from $28.62M to $28.64M.
D
Sell
11/10/2014Downgrade
Fluidigm Corporation (FLDM) was downgraded to D+ from C- on 11/10/2014 due to a decline in the growth index, valuation index and solvency index. Operating cash flow declined 2,940.71% from $312 to -$8.86M, and debt to equity increased from 1.21 to 1.26.
Fluidigm Corporation (FLDM) was downgraded to D+ from C- on 11/10/2014 due to a decline in the growth index, valuation index and solvency index. Operating cash flow declined 2,940.71% from $312 to -$8.86M, and debt to equity increased from 1.21 to 1.26.
C
Hold
10/27/2014Upgraded
Fluidigm Corporation (FLDM) was upgraded to C- from D+ on 10/27/2014 due to an increase in the valuation index and total return index.
Fluidigm Corporation (FLDM) was upgraded to C- from D+ on 10/27/2014 due to an increase in the valuation index and total return index.
D
Sell
9/22/2014Downgrade
Fluidigm Corporation (FLDM) was downgraded to D+ from C- on 9/22/2014 due to a decline in the valuation index and volatility index.
Fluidigm Corporation (FLDM) was downgraded to D+ from C- on 9/22/2014 due to a decline in the valuation index and volatility index.
C
Hold
9/5/2014Upgraded
Fluidigm Corporation (FLDM) was upgraded to C- from D+ on 9/5/2014 due to an increase in the valuation index.
Fluidigm Corporation (FLDM) was upgraded to C- from D+ on 9/5/2014 due to an increase in the valuation index.
D
Sell
8/6/2014Downgrade
Fluidigm Corporation (FLDM) was downgraded to D+ from C- on 8/6/2014 due to a major decline in the volatility index, solvency index and growth index. Operating cash flow declined 102.96% from -$10.55M to $312, the quick ratio declined from 6.29 to 3.96, and earnings per share declined from -$0.573 to -$0.4536.
Fluidigm Corporation (FLDM) was downgraded to D+ from C- on 8/6/2014 due to a major decline in the volatility index, solvency index and growth index. Operating cash flow declined 102.96% from -$10.55M to $312, the quick ratio declined from 6.29 to 3.96, and earnings per share declined from -$0.573 to -$0.4536.
C
Hold
7/22/2014Upgraded
Fluidigm Corporation (FLDM) was upgraded to C- from D+ on 7/22/2014 due to an increase in the valuation index.
Fluidigm Corporation (FLDM) was upgraded to C- from D+ on 7/22/2014 due to an increase in the valuation index.
D
Sell
7/3/2014Downgrade
Fluidigm Corporation (FLDM) was downgraded to D+ from C- on 7/3/2014 due to a decline in the volatility index and valuation index.
Fluidigm Corporation (FLDM) was downgraded to D+ from C- on 7/3/2014 due to a decline in the volatility index and valuation index.
C
Hold
6/2/2014Upgraded
Fluidigm Corporation (FLDM) was upgraded to C- from D+ on 6/2/2014 due to an increase in the valuation index.
Fluidigm Corporation (FLDM) was upgraded to C- from D+ on 6/2/2014 due to an increase in the valuation index.
D
Sell
5/16/2014Downgrade
Fluidigm Corporation (FLDM) was downgraded to D+ from C- on 5/16/2014 due to a major decline in the growth index, total return index and solvency index. Operating cash flow declined 425.73% from $3.24M to -$10.55M.
Fluidigm Corporation (FLDM) was downgraded to D+ from C- on 5/16/2014 due to a major decline in the growth index, total return index and solvency index. Operating cash flow declined 425.73% from $3.24M to -$10.55M.
C
Hold
3/14/2014Downgrade
Fluidigm Corporation (FLDM) was downgraded to C- from C on 3/14/2014 due to a decline in the volatility index, growth index and efficiency index. Operating cash flow declined 347.55% from -$1.31M to $3.24M, and total capital declined 0.62% from $97.01M to $96.41M.
Fluidigm Corporation (FLDM) was downgraded to C- from C on 3/14/2014 due to a decline in the volatility index, growth index and efficiency index. Operating cash flow declined 347.55% from -$1.31M to $3.24M, and total capital declined 0.62% from $97.01M to $96.41M.
NASDAQ
04/02/2025 4:00PM Eastern
Quotes delayed
